WO2001036667A1 - Procede de detection automatique d'un gene cible et applications d'un detecteur utilise dans ce procede - Google Patents
Procede de detection automatique d'un gene cible et applications d'un detecteur utilise dans ce procede Download PDFInfo
- Publication number
- WO2001036667A1 WO2001036667A1 PCT/CN1999/000192 CN9900192W WO0136667A1 WO 2001036667 A1 WO2001036667 A1 WO 2001036667A1 CN 9900192 W CN9900192 W CN 9900192W WO 0136667 A1 WO0136667 A1 WO 0136667A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- array
- gene
- quartz
- dna
- detection method
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 92
- 238000001514 detection method Methods 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 title claims abstract description 78
- 239000010453 quartz Substances 0.000 claims abstract description 85
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 85
- 239000000523 sample Substances 0.000 claims abstract description 76
- 239000013078 crystal Substances 0.000 claims abstract description 71
- 238000009396 hybridization Methods 0.000 claims abstract description 67
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 230000008859 change Effects 0.000 claims description 16
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 14
- 229910052709 silver Inorganic materials 0.000 claims description 14
- 239000004332 silver Substances 0.000 claims description 14
- 238000012360 testing method Methods 0.000 claims description 14
- 230000000295 complement effect Effects 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 12
- 239000002184 metal Substances 0.000 claims description 11
- 229910052751 metal Inorganic materials 0.000 claims description 11
- 108091034117 Oligonucleotide Proteins 0.000 claims description 9
- 239000012634 fragment Substances 0.000 claims description 9
- 229910052737 gold Inorganic materials 0.000 claims description 9
- 239000010931 gold Substances 0.000 claims description 9
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 8
- 238000001179 sorption measurement Methods 0.000 claims description 6
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000003753 real-time PCR Methods 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 2
- 238000011191 terminal modification Methods 0.000 claims description 2
- 238000007747 plating Methods 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 47
- 150000007523 nucleic acids Chemical class 0.000 abstract description 6
- 102000039446 nucleic acids Human genes 0.000 abstract description 5
- 108020004707 nucleic acids Proteins 0.000 abstract description 5
- 238000011065 in-situ storage Methods 0.000 abstract description 4
- 238000003380 quartz crystal microbalance Methods 0.000 abstract description 4
- 108020004414 DNA Proteins 0.000 description 71
- 239000010410 layer Substances 0.000 description 19
- 230000035945 sensitivity Effects 0.000 description 17
- 230000010355 oscillation Effects 0.000 description 13
- 102000053602 DNA Human genes 0.000 description 12
- 238000003752 polymerase chain reaction Methods 0.000 description 12
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 238000011160 research Methods 0.000 description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000011161 development Methods 0.000 description 7
- 230000002068 genetic effect Effects 0.000 description 7
- 239000007791 liquid phase Substances 0.000 description 7
- 238000002372 labelling Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000000018 DNA microarray Methods 0.000 description 5
- 101000674278 Homo sapiens Serine-tRNA ligase, cytoplasmic Proteins 0.000 description 5
- 101000674040 Homo sapiens Serine-tRNA ligase, mitochondrial Proteins 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 108020003215 DNA Probes Proteins 0.000 description 4
- 239000003298 DNA probe Substances 0.000 description 4
- 108020004682 Single-Stranded DNA Proteins 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 3
- 238000001069 Raman spectroscopy Methods 0.000 description 3
- 102100040516 Serine-tRNA ligase, cytoplasmic Human genes 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000001917 fluorescence detection Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 238000007899 nucleic acid hybridization Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 3
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 2
- 229960000975 daunorubicin Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 208000016361 genetic disease Diseases 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 101150065069 Hsp90b1 gene Proteins 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000004734 constant current stripping potentiometry Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 238000003891 environmental analysis Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004374 forensic analysis Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000005660 hydrophilic surface Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000012625 in-situ measurement Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000001948 isotopic labelling Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000003950 stripping voltammetry Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 231100000033 toxigenic Toxicity 0.000 description 1
- 230000001551 toxigenic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
- G01N29/02—Analysing fluids
- G01N29/022—Fluid sensors based on microsensors, e.g. quartz crystal-microbalance [QCM], surface acoustic wave [SAW] devices, tuning forks, cantilevers, flexural plate wave [FPW] devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N29/00—Investigating or analysing materials by the use of ultrasonic, sonic or infrasonic waves; Visualisation of the interior of objects by transmitting ultrasonic or sonic waves through the object
- G01N29/02—Analysing fluids
- G01N29/036—Analysing fluids by measuring frequency or resonance of acoustic waves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00608—DNA chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
- B01J2219/00704—Processes involving means for analysing and characterising the products integrated with the reactor apparatus
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/02—Indexing codes associated with the analysed material
- G01N2291/025—Change of phase or condition
- G01N2291/0255—(Bio)chemical reactions, e.g. on biosensors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/02—Indexing codes associated with the analysed material
- G01N2291/025—Change of phase or condition
- G01N2291/0256—Adsorption, desorption, surface mass change, e.g. on biosensors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2291/00—Indexing codes associated with group G01N29/00
- G01N2291/04—Wave modes and trajectories
- G01N2291/042—Wave modes
- G01N2291/0426—Bulk waves, e.g. quartz crystal microbalance, torsional waves
Definitions
- the present invention relates to a method for automatically detecting a combined target gene, and a detector manufactured based on the method. Background technique
- the main purpose of the present invention is to provide an automatic detection method of target genes for genetic diagnosis, genotyping, and forensic and environmental analysis of human genetic diseases, tumors and infectious diseases using in vitro gene chip technology.
- Another object of the present invention is to provide a tester which can be used for scientific research, clinical use, and manufactured based on the above method.
- a brief description of the detection method of the present invention is to use a microfabrication technique to directly etch an ultra-thin quartz resonator array or a single quartz resonator on a quartz crystal, and then develop a highly sensitive, in-situ hybridization monitor based on this.
- the miniature quartz resonance gene sensor chip establishes a non-labeled gene sensor detection technology with detection sensitivity equivalent to the current labeled DNA probe technology.
- the gene sensor chip has a large amount of DNA and probe array fixed, it can solve the existing gene Detection technology can only detect problems with a small amount of genetic information.
- the basic working principle of using the piezoelectric gene sensor for target gene detection according to the present invention is as follows: a large number of probe molecules are fixed on a quartz body support coated with a gold or silver film layer (two sides of the body pass through silver electrodes Apply a certain voltage), and then hybridize with the sample in the reaction cell. Because hybridization will cause the resonance frequency of the quartz crystal to change, the presence or absence of target molecules and the number of samples can be determined by detecting the change in the resonance frequency of the quartz body. BRIEF DESCRIPTION OF THE DRAWINGS
- FIG. 2 is a cross-sectional view taken along the line A-A of the chip described in FIG. 1;
- FIG. 3 is a schematic diagram of electrode surface probe fixation in the combined target gene automatic detection method according to the present invention.
- FIG. 4 is a schematic diagram of the detection results of the combined target gene detector according to the present invention on HPV and LT, wherein the Y-axis is a frequency reduction value and the X-axis is time;
- FIG. 5 is a schematic flowchart of an automatic detection method of a combined target gene according to the present invention.
- FIG. 6 is a schematic diagram of a circuit of a combined target gene automatic detector according to the present invention and connection modes of various components.
- the method of the present invention is characterized in that a combination of gene chip technology and piezoelectric sensor technology is used to form a unique detection method.
- the invention utilizes microfabrication technology to directly etch an ultra-thin quartz resonator array on a quartz crystal.
- the resonance frequency of the quartz crystal is very sensitive to fine changes in the surface quality of the crystal, so its quality detection limit can reach pg level.
- the microfabrication technology makes the quartz resonator array easy to prepare in batches, the cost can be greatly reduced.
- the effect of external mechanical pressure on a crystal to generate a charge on its surface is called the piezoelectric effect.
- the piezoelectric phenomenon of some crystals such as quartz, and pointed out that when certain dielectric substances are deformed by an external force in a certain direction, polarization will occur inside and a charge will be generated on the surface. When the external force is removed, it returns to the uncharged state again. Moreover, the charge formed on the crystal surface is directly proportional to the applied pressure. The phenomenon of converting this mechanical energy into electrical energy in the prior art is called the "paramagnetic effect" .
- piezoelectric materials having a piezoelectric effect are collectively referred to as piezoelectric materials.
- the more common piezoelectric materials are quartz, ceramics, etc. Among them, quartz has become a main component of piezoelectric sensing, especially piezoelectric electrochemical and piezoelectric biosensors due to its good mechanical, electrochemical, and temperature properties.
- Quartz is an anisotropic crystal. When the crystal is cut in different directions, its physical properties (such as elasticity, piezoelectric effect, and temperature characteristics) vary widely.
- the researchers of the present invention found that when an alternating excitation voltage is applied to the electrodes on both sides of the piezoelectric crystal, the crystal will generate mechanical deformation and oscillation. When the frequency of the alternating voltage reaches the natural frequency of the crystal, the amplitude will increase and a piezoelectric resonance will be formed. This specific frequency is called the resonance frequency.
- Sauerbrey first derived the relationship between the mass of the material carried on the surface of the crystal and the resonance frequency shift (2-1) by vibrating in the gas phase through AT-cut quartz crystals, and based on this, proposed the use of piezoelectric crystals as sensitive microbalances. Therefore, this formula is often called the Sauerbrey equation. P « A
- AF Frequency variation (Hz) caused by the coating.
- A The surface area of the quartz wafer (cm 2 ).
- quartz crystal microbalances are not only sensitive to mass, but are also excited by external temperature, air pressure, magnetic field fluctuations, shock oscillations, and liquid density, viscosity, dielectric constant, conductance, and flow through the crystal. Influence of factors such as current fluctuations.
- the prior art shows that after a voltage is applied to the two ends of the piezoelectric quartz crystal, the frequency of the piezoelectric quartz crystal under pressure is fixed.
- the researchers of the present invention fix the probe on the piezoelectric crystal. This will cause the overall frequency to change.
- the frequency after the change is still a fixed value; however, because external factors will cause the frequency to drift, the present invention adopts the following measures, that is, setting a reference detection. Only one probe is cured, then a crystal with the same probe cured is used as a reference test. If an ultra-thin quartz resonator array is obtained by etching the same crystal, the same probe is selected to be cured in the array. One is used as a reference test so that a stable reference frequency and true and reliable experimental results can be obtained.
- the change in the frequency of the quartz crystal brought by the different solidified probes can be easily detected by the prior art.
- a DNA molecule is composed of two parallel polynucleotide strands in opposite directions, and the two strands have chemically opposite directions. That is, the structure of P_5'-ribose- 3'_P ... is opposite to the structure of P-3'-ribose- 5'_P ....
- the two chains are mainly connected by hydrogen bonds between the bases: the plane of the base pair passes through the spiral axis and is approximately perpendicular to the spiral axis. Two hydrogen bonds can be formed between ATs and three hydrogen bonds can be formed between GCs. Meanwhile, for DNA double For the stability of the spiral structure, the force of a hydrophobic bond is also required.
- each chain can have any base sequence, but due to the regularity of base pairing, if the base sequence of one chain is determined, the other chain must be There is a corresponding base sequence.
- hybridization Since the double helix structure of DNA is mainly maintained by hydrogen bonds and hydrophobic bonds, all factors that can destroy the hydrogen and hydrophobic bonds, such as heating, acid-base, and organic solvents, can cause denaturation, making the double helix structure of DNA into random clusters. .
- the "renaturation" between different denatured DNA fragments by complementary base pairing is called hybridization. Hybridization can occur not only between DNA and DNA strands, but also between homologous sequences of DNA and RNA strands. During the hybridization process, two complementary single-stranded DNAs form a double bond hybrid in a non-covalent manner.
- the hybridization process can be used to detect whether the unknown DNA sample contains DNA complementary to the known sequence.
- the DNA double helix may exist in different conformations; however, short-stranded DNA molecules in dry conditions are still It has a certain rigidity, and the space distance of the oligonucleotides fixed on the electrodes is very small. Because the fixed DNA is formed on the wafer, the mass of the fixed oligonucleotide probe is relative to the mass of the crystal itself. It is very small, so it can meet the requirements of the present invention.
- the basic working principle of using a piezoelectric gene sensor for target gene detection is as follows: a section of a gene is fixed on a solid support.
- the fixed support may be a piezoelectric quartz crystal.
- a voltage is applied to the two ends of the piezoelectric quartz crystal through a silver electrode to obtain a fixed frequency, and then it is used to hybridize with a complementary oligonucleotide in solution.
- the change in mass load and viscous coupling in the hybridization process results in The frequency of the quartz piezoelectric crystal changes.
- the fixation of the known gene fragments on the support is shown in Figure 3.
- gene sensors also known as DNA and nucleic acid biosensors
- Gene sensors are unique in molecular biology and medicine due to their unique advantages of simplicity, fastness, and low cost.
- the fields of inspection and environmental monitoring have a wide range of application prospects.
- gene sequence analysis, gene mutation, gene detection and diagnosis it also involves research on the interactions between DNA, drugs, and proteins.
- Reversible hybridization of complementary DNA is the basis of biological processes such as replication, transcription, and translation. Nucleic acid hybridization is essential for understanding these important biological processes at the molecular level.
- the method of gene analysis mainly detects the specific DNA sequence in a heterogeneous system.
- the more commonly used method is nucleic acid hybridization. Nucleic acid hybridization is a process in which two complementary single-stranded DNAs form a double bond hybrid by non-covalent bonding. When the sequence of one of the strands is known, this is a very useful analysis technique. By detecting the hybridization process, you can find out whether the unknown DNA sample contains DNA complementary to the known sequence.
- the most commonly used method is A solid support is immobilized with a known sequence of genes, and then used in the solution Hybridization is performed with complementary oligonucleotides in the liquid, so that specific DNA in the liquid can be detected.
- DNA hybridization reactions require the use of labeling methods to detect hybridization signals. These methods allow in situ detection and can be highly sensitive. For example: The detection limit of PCR technology can reach nmol / 1; DNA computer technology also provides a method for detecting a specific DNA sequence from a large number of mixed systems; Due to the application of short-wave fluorescence and confocal microscope technology, fluorescent labeling has become a detection Trace legs are very sensitive and commonly used methods.
- DNA biosensor systems which detect and identify DNA sequences through hybridization methods, and can carry out quantitative DNA research.
- This detection method is simple, time-consuming, and does not require signal molecules to perform quantitative analysis directly. It can be used not only for the determination of DNA sequences and gene point mutations, but more importantly, it can monitor the progress of hybridization reactions dynamically and quantitatively, without the need to clean the electrodes or dry, and directly obtain hybridization information in the liquid state.
- a DNA biosensor immobilizes a modified DNA probe on a conversion unit that converts a physical or chemical signal into an electrical signal.
- DNA biosensors can be divided into electrochemical, optical, and piezoelectric crystal sensors according to the selected medium and transducer.
- the researchers mainly applied the quartz crystal microbalance QCM (Quartz Crystal icrobalance) technology, which is a piezoelectric sensor technology combined with gene chip technology to detect DNA, and compared the response time and hybridization efficiency of the sensors with different fixing methods. Impact.
- QCM Quadrat Crystal icrobalance
- Henke et al Used an ethidium bromide hybridization indicator and total internal reflection fluorescence method to determine the hybridization reaction on the fiber surface, studied the preparation of fluorescent fiber DNA sensors, and compared the single-stranded DNA on the fiber surface by means of scattering and UV-UIS spectroscopy.
- the results of the two immobilization methods indicate that it is difficult to directly fix the oligonucleotide to the amino terminal of the hydrophobic linker on the surface, but the amide coupling reaction can successfully immobilize.
- Uddion et al Used a DNA synthesizer to synthesize oligonucleotides directly on the surface of the quartz fiber after the linker treatment.
- dsDNA embedded in ethidium bromide has developed a fiber-optic DNA sensor for fluorescence detection, which is used to detect the formation of triple helix DNA.
- Abel et al. [ 1] developed an automatic optical DNA sensor system. The principle is to fix a biotin-labeled probe on the surface of an optical fiber with avidin or streptavidin, and use the fluorescence excitation and detection of the loss field of quartz fiber to realize the probe.
- On-site monitoring of hybridization with fluorescein-labeled complementary strands with a sensitivity of 132 pmoL. Compared with fluorescence detection, surface-enhanced Raman detection has higher sensitivity.
- the surface-enhanced Raman (SERS) reagent modified gene probe can be directly used for gene detection without amplification.
- Graham et al. Reported a SERS gene probe with a sensitivity of 0.8 pmol.
- Isola et al. Combined SERS technology with spectral selectivity and high sensitivity with PCR technology to detect HIV-Gag genes.
- the SERS technology requires expensive and complicated equipment, based on its extremely small spectral bandwidth (half-peak width ⁇ 11 ⁇ 1), it is expected that multiple SERS gene probes can be used to simultaneously detect multiple target genes on one chip. This is difficult to achieve by general optical detection technology (such as the half-peak width of 50-100nm for fluorescence detection).
- SPR Surface plasmon resonance
- the laboratory constructed an array of 2x2 oligonucleotide probes (probe spot diameter about 2.0mm) on the surface of the gold membrane. Detecting multiple DNA hybrids simultaneously using on-site microscopy SPR technology. This study has initially demonstrated the feasibility of using SPR technology for DNA chip detection.
- the electrochemical gene sensors produced are difficult to be popularized due to their poor accuracy and relinearity. Therefore, the current research is mainly on the development of electrochemical gene sensors that are expected to be disposable, using microfabrication technology that is easy to mass-produce.
- Wang's laboratory has developed a series of miniature DNA thick-film carbon electrodes using screen printing technology.
- Applications include detection of nucleic acid sequences based on hybridization methods, embedding of dsDNA by drugs and agricultural products, or determination of these small molecules by their effects on the oxidation signal of nucleobases.
- the laboratory has proposed the use of a highly sensitive constant current stripping chronopotentiometry to detect DNA hybridization recognition.
- the DNA sequences measured include M. Tuberculosis, HIV-I, E .Coli, Protozoan crypyosporidium parvum, etc. Hashimoto et al. Used photolithographic microfabrication technology to etch out a 0.3mm diameter micro-gold electrode with a fixed DNA probe, which can be used once, and the electroactive substance Hoechst 33258 was used as a hybridization indicator to detect the patient's serum HBV-DNA. concentration.
- Singhal and Kuhr proposed the use of electrocatalytic oxidation of ribose and amino groups on the copper surface, and proposed a DNA electrochemical sensor different from the current detection of adenine and guanine nucleobase oxidation. Since all nucleotides and DNA molecules contain ribose and amino groups, this type of sensor is suitable for the determination of various types of nucleotides.
- Piezoelectric gene sensors are based on the sensitivity of bulk acoustic wave devices-piezoelectric quartz resonators to changes in their surface quality (mass sensitivity can reach ng level). No hybridization indicator is needed to directly detect the DNA hybridization reaction on the sensor surface. Such sensors are also called Bulk acoustic and quartz (crystal) micro / nanobalance DNA sensors.
- Nicolili et al Used LB membrane technology to deposit a monolayer of ssDNA mixed with fatty amine on a quartz resonator using LB membrane technology, which has good hybridization activity; Fawcett et al.
- piezoelectric gene sensors were mostly used to detect changes in the quality of the dry surface of the sensor before and after hybridization.
- the on-site monitoring of the hybridization process makes piezoelectric gene sensors easier and faster;
- the study of the kinetics of the surface hybridization process provides a basis for the optimization of gene sensors.
- the earliest research in this area was Okahato Lab.
- Gene probes-Immobilization of single-stranded DNA fragments (oligonucleotides) on the sensor surface is the primary and basic condition for gene sensors.
- the method used in the present invention includes three probe immobilization methods: adsorption method, covalent bonding method, and combination method.
- adsorption method adsorption method
- covalent bonding method adsorption method
- combination method adsorption method
- the latter two types of methods in the prior art are adopted.
- a solid probe modification layer can be obtained, the surface hybridizes.
- Anti There should be few active sites and the method is complicated.
- terminally modified probes to form stable, highly ordered monolayers (SAMs) on the surface by using the self-assembly of molecules with certain structures.
- SAMs highly ordered monolayers
- PCR Polymerase chain reaction
- the signal generated by the combination of some specimens and probes is relatively weak.
- the researchers of the present invention took the detection of human papilloma virus oncogene transcripts as an example, and for the first time tried to combine a field-capable piezoelectric gene sensor with PCR technology Construct a new type of real-time PCR technology; in other words, in order to increase the signal intensity, the present invention adopts the method of first performing PCR amplification on the specimen, or adopting the method of real-time PCR amplification to improve the signal intensity and detection sensitivity.
- the detection steps of the automatic detection method of the target genome according to the present invention are as follows:
- the hybridization reaction system described here is composed of a base, a chip, and a lead; the hybridization reaction system changes the frequency parameters of the specimen and the probe after contact, and The data of the comparison detection parameters are fed back to a data acquisition and processing system, which includes a multi-channel test acquisition and real-time central signal processing.
- the multi-channel test acquisition is actually performed on multiple piezoelectric quartz crystals.
- the probes on the probe or a plurality of probes on a piezoelectric quartz crystal array are sequentially collected for the parameter changes caused by the combination with the specimen; the real-time central signal processing is finally represented by the channelized data display, data comprehensive processing, and image display. .
- the miniature piezoelectric quartz resonator described in the present invention can be a single quartz crystal solidified probe, or a miniature piezoelectric quartz resonator array can be used, so that a large number of etched quartz crystal A large number of probes are provided on the small block, as shown in FIG. 1, and usually at least 9 kinds of probes are provided.
- different types of probes that is, a plurality of specific gene fragments-nucleotide sequences
- Different types of probes have different genetic information; if only one probe is labeled, multiple samples of different sources can be detected and analyzed for the same genetic information (such as a certain pathogen: hepatitis B virus, etc.); such as
- hepatitis B virus a certain pathogen
- you can diagnose and analyze multiple genetic information of a specimen for example, when detecting hepatitis, multiple probes can be fixed to detect hepatitis A, B, and C).
- the miniature quartz resonance array gene sensor chip of the present invention uses a microfabrication technology to directly etch an ultra-thin quartz resonator array on a quartz crystal, and then fixes a large number of probe molecules to the quartz crystal plated with gold or silver film. On the support, a certain voltage is applied to both sides of the crystal through a silver electrode, and then the probe is hybridized with the specimen. The hybridization will cause the resonance frequency of the quartz crystal to change. The sample can be judged by detecting the change value of the resonance frequency of the quartz crystal. The presence or absence of target molecules and the number.
- the basic working principle of using a piezoelectric gene sensor chip for target gene detection is as follows: a section of a gene is fixed on a solid support, specifically, the fixed support may be a piezoelectric quartz crystal, A voltage is applied to the two ends of the piezoelectric quartz crystal through a silver electrode to obtain a fixed frequency, and then it is used to hybridize with a complementary oligonucleotide in solution. The change in mass load and viscous coupling in the hybridization process passes As a result, the frequency of the quartz piezoelectric crystal is changed. By analyzing the change value of the frequency, whether to hybridize and the number of hybridizations can be obtained, thereby realizing the detection of specific DNA in the liquid phase.
- the fixation of the known gene fragments on the support is shown in Figure 3.
- the miniature piezoelectric quartz resonator array gene sensor chip of the present invention includes an AT-cut quartz crystal 3 etched into an array, A metal film layer 4 is plated on the lower surface of the quartz crystal, a metal film layer 2 in the same array is plated on the upper surface of the quartz crystal array, and a probe array layer 1 is cured on the upper surface of the upper metal film layer 2 in the array.
- the electrode 6 is fixed at the corresponding probe 7, and the lower metal film layer is thermally bonded to the base 5.
- the number of the array is at least one, preferably at least six, and most preferably at least nine.
- the number of blocks of the array is the same as the number of cured probe layers 1; grooves 9 are provided between the blocks presented by the array; the metal film layer may be a gold film layer or a silver film layer;
- the electrode is a silver electrode; the base is a glass base; in order to reduce the influence of other factors, one of the same probes cured in the array is used as a reference detection; the curing used in the present invention method Be an adsorption method, covalent bonding method and the combination method, but preferably sulfhydryl terminus modification covalent bonding method.
- the steps of the detection method according to the present invention are as follows:
- Specimen processing Extraction of nucleic acids from specimens, endonuclease treatment (different enzymes for different specimens), separation and purification of target fragments according to different samples, etc .;
- the detector according to the present invention preferably uses a one-time chip
- the multi-channel (well) reaction device according to the present invention has been produced by the applicant and sold publicly.
- the automatic method of the target genome according to the present invention uses bioengineering, molecular biology, sensors, micro-processing technology, etc., and its main uses include the diagnosis of diseases (infectious diseases, genetic diseases, tumors, cardiovascular diseases, etc.), Detection of genetic mutations, development of new drugs and environmental monitoring.
- Table 1 The detection performance of the target gene automatic detector constructed by the method of the present invention is shown in Table 1 below: Table 1
- the chip constructed by the miniature piezoelectric quartz resonator array used by the present invention has a sensitivity of up to pg; the specificity and the currently used label detection The technology is the same.
- the target gene automatic detector constructed by the method of the invention has the advantages of in situ measurement, no labeling, detection information available at any time, small size, easy to carry, convenient to use, and low cost, and is suitable for clinical and field environment detection. .
- FIG. 6 is a schematic circuit diagram of the detector according to the present invention.
- Example 1 Except for the chip, each part of the circuit of the present invention can adopt circuits in the prior art.
- One of the contributions of the present invention is to combine the detection circuits with the chip of the present invention to achieve the present invention. Purpose The following are examples, which are only used to illustrate the present invention, but not to limit the present invention. Example 1
- Tables 3 and 4 are comparisons of the results of detection of Mycobacterium tuberculosis and Neisseria gonorrhoeae (specified specimens) with conventional culture methods, PCR methods, and the methods and detectors described in the present invention.
- the negative specimens were 1, 8, 9, 10, 11, 14, 15, 18, 19, 20, 21, 22, 23, 26, 27, and the rest were positive;
- the negative specimens were 1, 6, 7, 9, 11, 18, 19, 21, 22, 27, 28, and the rest were positive.
- the conventional culture method is more accurate and objective, but has limited sensitivity.
- the PCR method has high sensitivity but is prone to false positives. From the experimental data, regardless of accuracy or sensitivity, the automatic target gene detector according to the present invention The detection effect is better than these two methods.
- the target gene automatic detection method and the detector constructed by the method are characterized by a combination of a DNA chip and a sensor technology, and have the following advantages.
- MGI one + ten + + + ten + one-sample number 11 12 13 14 15 16 17 18 19 20 cultivation- ⁇ ten-one one ⁇ -
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Acoustics & Sound (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN1999/000192 WO2001036667A1 (fr) | 1999-11-16 | 1999-11-16 | Procede de detection automatique d'un gene cible et applications d'un detecteur utilise dans ce procede |
| AU12576/00A AU1257600A (en) | 1999-11-16 | 1999-11-16 | Combinatorial and automatic detection method of target gene, and a detector using the method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN1999/000192 WO2001036667A1 (fr) | 1999-11-16 | 1999-11-16 | Procede de detection automatique d'un gene cible et applications d'un detecteur utilise dans ce procede |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2001036667A1 true WO2001036667A1 (fr) | 2001-05-25 |
Family
ID=4575151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN1999/000192 WO2001036667A1 (fr) | 1999-11-16 | 1999-11-16 | Procede de detection automatique d'un gene cible et applications d'un detecteur utilise dans ce procede |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1257600A (fr) |
| WO (1) | WO2001036667A1 (fr) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5501986A (en) * | 1988-04-06 | 1996-03-26 | E. I. Du Pont De Nemours And Company | Piezoelectric specific binding assay with mass amplified reagents |
| US5661028A (en) * | 1995-09-29 | 1997-08-26 | Lockheed Martin Energy Systems, Inc. | Large scale DNA microsequencing device |
| WO1998010122A1 (fr) * | 1996-09-03 | 1998-03-12 | Northeastern University | Reseau capillaire hybride a microstructure et ensemble de detection a canaux multiples |
-
1999
- 1999-11-16 WO PCT/CN1999/000192 patent/WO2001036667A1/fr active Application Filing
- 1999-11-16 AU AU12576/00A patent/AU1257600A/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5501986A (en) * | 1988-04-06 | 1996-03-26 | E. I. Du Pont De Nemours And Company | Piezoelectric specific binding assay with mass amplified reagents |
| US5661028A (en) * | 1995-09-29 | 1997-08-26 | Lockheed Martin Energy Systems, Inc. | Large scale DNA microsequencing device |
| WO1998010122A1 (fr) * | 1996-09-03 | 1998-03-12 | Northeastern University | Reseau capillaire hybride a microstructure et ensemble de detection a canaux multiples |
Also Published As
| Publication number | Publication date |
|---|---|
| AU1257600A (en) | 2001-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Rapid and ultrasensitive electromechanical detection of ions, biomolecules and SARS-CoV-2 RNA in unamplified samples | |
| Kavita | DNA biosensors-a review | |
| Wang et al. | Rapid SARS-CoV-2 nucleic acid testing and pooled assay by tetrahedral DNA nanostructure transistor | |
| Zhang et al. | Rapid and label-free nanomechanical detection of biomarker transcripts in human RNA | |
| Zhang et al. | Label-free electrochemical DNA biosensor array for simultaneous detection of the HIV-1 and HIV-2 oligonucleotides incorporating different hairpin-DNA probes and redox indicator | |
| Nagraik et al. | Amalgamation of biosensors and nanotechnology in disease diagnosis: Mini-review | |
| Zhai et al. | DNA based biosensors | |
| KR100442822B1 (ko) | 전단응력 측정을 이용한 생분자들간의 결합 여부 검출 방법 | |
| Xu et al. | A review: electrochemical aptasensors with various detection strategies | |
| Yao et al. | Biosensors for hepatitis B virus detection | |
| EP1341933A4 (fr) | Procedes bases sur un signal electrique transitoire et dispositifs permettant de caracteriser l'interaction et/ou le mouvement moleculaires dans un echantillon | |
| Tombelli | Piezoelectric biosensors for medical applications | |
| Li et al. | Peptide nucleic acid and antifouling peptide based biosensor for the non-fouling detection of COVID-19 nucleic acid in saliva | |
| Zhang et al. | Sequence specific label-free DNA sensing using film-bulk-acoustic-resonators | |
| CN112378971A (zh) | 一种CRISPR/Cas13a驱动的催化可再生电化学生物传感器及其应用 | |
| Yao et al. | An enzyme free electrochemical biosensor for sensitive detection of miRNA with a high discrimination factor by coupling the strand displacement reaction and catalytic hairpin assembly recycling | |
| Zari et al. | Label-free DNA biosensor for electrochemical detection of short DNA sequences related to human papilloma virus | |
| Schmidt et al. | Rolling circle amplification tailored for plasmonic biosensors: from ensemble to single-molecule detection | |
| Kumar et al. | DNA based biosensors for detection of pathogens | |
| CN1605861A (zh) | 电化学定量聚合酶链式反应检测芯片的制备和检测方法 | |
| Brett | DNA-based biosensors | |
| WO2001036667A1 (fr) | Procede de detection automatique d'un gene cible et applications d'un detecteur utilise dans ce procede | |
| CN1094520C (zh) | 组合靶基因自动检测方法 | |
| JP2012501174A (ja) | インピーダンス分光法を用いたdnaの測定 | |
| CN1296081A (zh) | 微型石英谐振阵列基因传感器芯片 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase |